CARBOPLATIN AND PEMETREXED FOR NON-SQUAMOUS NON-SMALL CELL LUNG CANCER - OVERALL SURVIVAL AND TOXICITY

被引：0
|
作者：
Andersen, R. [1 ]
Mellemgaard, A. [1 ]
机构：
[1] Herlev Univ Hosp, DK-2730 Herlev, Denmark
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：S73 / S73
页数：1
相关论文
共 50 条
  • [31] Association of comprehensive molecular genotyping and overall survival in patients with advanced non-squamous non-small cell lung cancer.
    Aggarwal, Charu
    Marmarelis, Melina Elpi
    Hwang, Wei-Ting
    Scholes, Dylan G.
    McWilliams, Tara
    Singh, Aditi Puri
    Sun, Lova
    Kosteva, John A.
    Costello, Michael Robert
    Cohen, Roger B.
    Langer, Corey J.
    Gabriel, Peter Edward
    Shulman, Lawrence N.
    Thompson, Jeffrey C.
    Carpenter, Erica L.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [32] Phase II trial of Pemetrexed Continuation - Maintenance after Carboplatin-based Induction in Untreated Non-squamous Non-small Cell Lung Cancer
    Minami, Seigo
    Kijima, Takashi
    Komuta, Kiyoshi
    Kumagai, Toru
    Imamura, Fumio
    Yokota, Soichiro
    Takeuchi, Yoshiko
    Nakatani, Takeshi
    Tachibana, Isao
    Kawase, Ichiro
    ANTICANCER RESEARCH, 2013, 33 (12) : 5535 - 5542
  • [33] Community experience of implementing carboplatin, pemetrexed and pembrolizumab treatment in the North East England population for non-squamous non-small cell lung cancer (NSCLC)
    Kohli, S.
    Greystoke, A.
    Gardiner, J.
    LUNG CANCER, 2020, 139 : S53 - S53
  • [34] A phase I study of binimetinib (MEK 162), a MEK inhibitor, plus carboplatin and pemetrexed chemotherapy in non-squamous non-small cell lung cancer
    Fung, A. S.
    Graham, D. M.
    Chen, E. X.
    Stockley, T. L.
    Zhang, T.
    Le, L. W.
    Albaba, H.
    Pisters, K. M.
    Bradbury, P. A.
    Trinkaus, M.
    Chan, M.
    Arif, S.
    Zurawska, U.
    Rothenstein, J.
    Zawisza, D.
    Effendi, S.
    Gill, S.
    Sawczak, M.
    Law, J. H.
    Leighl, N. B.
    LUNG CANCER, 2021, 157 : 21 - 29
  • [35] Cemiplimab monotherapy in advanced non-squamous and squamous non-small cell lung cancer
    Rosell, Rafael
    Gonzalez-Cao, Maria
    LANCET, 2021, 397 (10274): : 557 - 559
  • [36] Pemetrexed in maintenance treatment of advanced non-squamous non-small-cell lung cancer
    Minami, Seigo
    Kijima, Takashi
    LUNG CANCER-TARGETS AND THERAPY, 2015, 6 : 13 - 25
  • [37] Pemetrexed for non-squamous non-small-cell lung cancer: experience in Northern Ireland
    Mulligan, C.
    Campbell, L.
    McAleese, J.
    Scullin, P.
    LUNG CANCER, 2011, 71 : S6 - S6
  • [38] Haematological toxicity of pemetrexed in patients with metastatic non-squamous non-small cell carcinoma of lung with third-space fluid
    Kwok, Wang Chun
    Cheong, Tan Fong
    Chiang, Ka Yan
    Ho, James Chung Man
    Lam, David Chi Leung
    Ip, Mary Sau Man
    Tam, Terence Chi Chun
    LUNG CANCER, 2021, 152 : 15 - 20
  • [39] Pemetrexed and Cisplatin for Advanced Non-squamous Non-small Cell Lung Cancer in Japanese Patients: Phase II Study
    Kawano, Yuko
    Ohyanagi, Fumiyoshi
    Yanagitani, Noriko
    Kudo, Keita
    Horiike, Atsushi
    Tanimoto, Azusa
    Nishizawa, Hironari
    Ichikawa, Atsuo
    Sakatani, Toshio
    Nakatomi, Katsumi
    Hagiwara, Sachiko
    Ninomiya, Hironori
    Motoi, Noriko
    Ishikawa, Yuichi
    Horai, Takeshi
    Nishio, Makoto
    ANTICANCER RESEARCH, 2013, 33 (08) : 3327 - 3333
  • [40] Pemetrexed(P) in Third and Fourth Line Chemotherapy for Advanced Non-Small Cell Lung Cancer (Non-Squamous)-aNSCLCns
    Grigorescu, Alexandru Calin
    Ilie, Dan
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S929 - S929
12345